Kerckhoff-Klinik

Reduced leaflet motion after transcatheter aortic-valve replacement (2020) de Backer O, Dangas GD, Jilaihawi H, Leipsic JA, Terkelsen CJ, Makkar R, Kini AS, et al. Journal article Impact of coronary calcification on outcomes after ABSORB scaffold implantation: Insights from the GABI-R registry (2020) Hemetsberger R, Abdelghani M, Mankerious N, Allali A, Toelg R, Gori T, Achenbach S, et al. Journal article COVID-19 among heart transplant recipients in Germany: a multicenter survey (2020) Rivinius R, Kaya Z, Schramm R, Boeken U, Provaznik Z, Heim C, Knosalla C, et al. Journal article Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland (2020) Juche A, Siegert E, Mueller-Ladner U, Riemekasten G, Günther C, Kötter I, Henes J, et al. Journal article Randomized Clinical Trial Comparing a Rivaroxaban-Based Strategy With an Antiplatelet-Based Strategy for the Prevention of Subclinical Leaflet Thrombosis in Transcatheter Aortic Valves (GALILEO-4D) (2019) De Backer O, Dangas G, Jilaihawi H, Leipsic J, Terkelsen CJ, Makkar R, Kini AS, et al. Conference contribution Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019: Evidenzbasierte Leitlinie der Deutschen Gesellschaft für Rheumatologie (DGRh) und der beteiligten medizinisch-wissenschaftlichen Fachgesellschaften und weiterer Organisationen (2019) Kiltz U, Braun J, Becker A, Chenot JF, Dreimann M, Hammel L, Heiligenhaus A, et al. Journal article, Review article Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration) (2019) Kim WK, Schäfer U, Tchetche D, Nef H, Avanzas P, Rudolph T, Scholtz S, et al. Journal article Does anti-acid treatment influence disease progression in SSc-ILD ? data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network (2019) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article